Latest Health News from Duke Medicine News and Communications
Search News
For Journalists
Reporters & producers can visit Duke Medicine News and Communications for contact information.
Arthritic Knees, But Not Hips, Have Robust Repair Response
Feb. 10, 2012
Researchers at Duke University Medical Center used new tools they developed to analyze knees and hips and discovered that osteoarthritic knee joints are in a constant state of repair, while hip joints are not.
Heart Disease May Be a Risk Factor for Prostate Cancer
Feb. 8, 2012
In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, suggesting the two conditions may have shared causes.
Copper + Love Chemical = Big Sulfur Stink
Feb. 6, 2012
When Hiroaki Matsunami, PhD, at Duke University set out to study a chemical in male mouse urine called MTMT that attracts female mice, he didn't think he would stumble into a new field of study.
Vaccines to Boost Immunity Where It Counts, Not Just Near Shot Site
Jan. 22, 2012
Researchers at Duke University Medical Center have created synthetic nanoparticles that target lymph nodes and greatly boost vaccine responses, said lead author Ashley St. John, PhD, a researcher at Duke-NUS Graduate Medical School.
New Way to Learn About -- and Potentially Block -- Traits in Harmful Pathogens
Jan. 9, 2012
Researchers at Duke University Medical Center have developed a new way to identify the genes of harmful microbes, particularly those that have been difficult to study in the laboratory.
Headphone Music Eases Anxiety During Prostate Biopsies
Jan. 9, 2012
Tuning in to tune out may be just what's needed for men undergoing a prostate biopsy, according to researchers at the Duke Cancer Institute.
Cancer Drugs Help the Hardest Cases of Pompe Disease
Jan. 5, 2012
Kids with Pompe disease fail because of a missing enzyme, GAA, that leads to dangerous sugar build-up, which affects muscles and movement. An enzyme replacement treatment pioneered at Duke University has saved many lives, but some children with Pompe disease produce an immune reaction that blocks the benefits of the life-saving enzyme treatment.
New Approach to Prostate Cancer Care Draws Patients with Riskiest Disease
Jan. 4, 2012
In choosing where they get treatment, prostate cancer patients tend to opt for a major cancer center if they have severe disease, but stick closer to home for less complicated cases, even when offered a model of care that taps numerous experts.
Short Hospitalizations for Heart Attacks May Increase Readmissions in U.S.
Jan. 3, 2012
Patients treated for acute heart attacks in the United States are readmitted within 30 days more often than in other countries, a finding explained in part by significantly shorter initial hospitalizations, according to an international study led by researchers at Duke University Medical Center.
Duke Celebrates Distinguished Fellows Who Have Advanced Science
Dec. 22, 2011
Five scientists from Duke University Medical Center and three from Duke University have been chosen for the distinct honor of fellow of the American Association for the Advancement of Science (AAAS). Election as an AAAS fellow is granted because of scientifically or socially distinguished efforts to advance science or its applications. Notably, three new fellows are from the Department of Molecular Genetics and Microbiology, and three are department chairs.
Feb. 10, 2012
Researchers at Duke University Medical Center used new tools they developed to analyze knees and hips and discovered that osteoarthritic knee joints are in a constant state of repair, while hip joints are not.
Heart Disease May Be a Risk Factor for Prostate Cancer
Feb. 8, 2012
In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, suggesting the two conditions may have shared causes.
Copper + Love Chemical = Big Sulfur Stink
Feb. 6, 2012
When Hiroaki Matsunami, PhD, at Duke University set out to study a chemical in male mouse urine called MTMT that attracts female mice, he didn't think he would stumble into a new field of study.
Vaccines to Boost Immunity Where It Counts, Not Just Near Shot Site
Jan. 22, 2012
Researchers at Duke University Medical Center have created synthetic nanoparticles that target lymph nodes and greatly boost vaccine responses, said lead author Ashley St. John, PhD, a researcher at Duke-NUS Graduate Medical School.
New Way to Learn About -- and Potentially Block -- Traits in Harmful Pathogens
Jan. 9, 2012
Researchers at Duke University Medical Center have developed a new way to identify the genes of harmful microbes, particularly those that have been difficult to study in the laboratory.
Headphone Music Eases Anxiety During Prostate Biopsies
Jan. 9, 2012
Tuning in to tune out may be just what's needed for men undergoing a prostate biopsy, according to researchers at the Duke Cancer Institute.
Cancer Drugs Help the Hardest Cases of Pompe Disease
Jan. 5, 2012
Kids with Pompe disease fail because of a missing enzyme, GAA, that leads to dangerous sugar build-up, which affects muscles and movement. An enzyme replacement treatment pioneered at Duke University has saved many lives, but some children with Pompe disease produce an immune reaction that blocks the benefits of the life-saving enzyme treatment.
New Approach to Prostate Cancer Care Draws Patients with Riskiest Disease
Jan. 4, 2012
In choosing where they get treatment, prostate cancer patients tend to opt for a major cancer center if they have severe disease, but stick closer to home for less complicated cases, even when offered a model of care that taps numerous experts.
Short Hospitalizations for Heart Attacks May Increase Readmissions in U.S.
Jan. 3, 2012
Patients treated for acute heart attacks in the United States are readmitted within 30 days more often than in other countries, a finding explained in part by significantly shorter initial hospitalizations, according to an international study led by researchers at Duke University Medical Center.
Duke Celebrates Distinguished Fellows Who Have Advanced Science
Dec. 22, 2011
Five scientists from Duke University Medical Center and three from Duke University have been chosen for the distinct honor of fellow of the American Association for the Advancement of Science (AAAS). Election as an AAAS fellow is granted because of scientifically or socially distinguished efforts to advance science or its applications. Notably, three new fellows are from the Department of Molecular Genetics and Microbiology, and three are department chairs.
